Spinal Cord Trauma Treatment Market Value Anticipated To Reach US$ 4,547.2 Million By 2027: Acumen Research And Consulting

by NASDAQ Market News February 8, 2021

NASDAQ Market News
Click here to email author

Sorrento Announces Subsidiary Company – ADNAB, Inc. – to Develop and Commercialize ADNAB™ Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic

Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules

Ads